Parisotto Shannon M sold $1.3M of CRL
Parisotto Shannon M (CEVP, Disc & Safety Assessment) sold 5,046 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $263.00 ($1.33M total) on 2026-08-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price ($263/share), and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may note the disclosed insider sale, but the 10b5-1 framing makes it less likely to drive a durable repricing.
What to watch
The filing does not indicate why the sale occurred, whether it was part of a broader planned schedule, or whether other insiders executed offsetting buys.
Background
The article is an SEC Form 4 insider transaction disclosure for Charles River Laboratories International, Inc.
Ticker impact
SEC Form 4 shows CRL officer Parisotto Shannon M sold 5,046 shares on 2026-08-05 for about $1.33M under a 10b5-1 plan.
Low likelihood of a sustained price move from this filing alone; any reaction is likely muted and short-lived.
The transaction is an open-market sale by an officer and explicitly states a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
Minimal. Insider 10b5-1 sales do not materially change biotech/life-science services demand expectations.
None.
None.
Counterpoint
Even with 10b5-1, clustered insider selling can coincide with internal risk management or tax planning, which some traders may still treat as a mild negative sentiment input.
Key entities
- issuerCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subject of the Form 4 insider transaction disclosure.
- insiderParisotto Shannon M
Officer (CEVP, Disc & Safety Assessment) who sold shares.
